Utah Medical Products Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, the company reported net sales of $9,832,000 against $9,907,000 a year ago. Operating income was $3,570,000 against $2,913,000 a year ago. Income before tax was $3,322,000 against $2,711,000 a year ago. Net income was $2,259,000 against $1,858,000 a year ago. Earnings per share were $0.606 against $0.509 a year ago.

For the year, the company reported net sales of $41,552,000 against $37,860,000 a year ago. Operating income was $15,196,000 against $11,842,000 a year ago. Income before tax was $14,537,000 against $11,080,000 a year ago. Net income was $10,169,000 against $7,414,000 a year ago. Earnings per share were $2.740 against $2.034 a year ago. ROE was 22% (prior to payment of dividends). Total consolidated sales were up 10% in 2012 primarily because the company had the benefit of Femcare's added sales for the full year compared to about 80% of the prior year.